If you liked this article you might like

Akorn Is Highly Coveted, But Tea Leaves Don't Read Bidding War
Judgment Day; The Good, the Bad and the Ugly: Doug Kass' Views
Starboard Value's Jeff Smith Is Top Activist for Naming New Board Members
Pharma, Biotech Stocks Fall on Trump Tweets, GOP Health Care Plan